![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
-Tocopherol in Smooth Muscle Cells1 ,2
Institute of Biochemistry and Molecular Biology, 3012 Bern, Switzerland
3To whom correspondence should be addressed. E-mail: angelo.azzi{at}mci.unibe.ch.
 |
ABSTRACT |
|---|
 TOP ABSTRACT INTRODUCTIONInhibition of PKC and...Transcriptional regulation of...{alpha}-Tocopherol-associated...REFERENCES |
|---|
-tocopherol, are not retained by humans. This suggests that
-tocopherol is recognized uniquely; therefore, it may exert an
exclusive function. -Tocopherol possesses distinct properties that
are independent of its prooxidant, antioxidant or
radical-scavenging ability. -Tocopherol specifically inhibits
protein kinase C, the growth of certain cells and the transcription of
the CD36 and collagenase genes. Activation events have also been seen
on the protein phosphatase 2A (PP2A) and on the expression
of other genes (-tropomyosin and connective tissue growth factor).
Neither ß-tocopherol nor probucol possessed the same specialty
functions as -tocopherol. Recently, we isolated a new ubiquitous
cytosolic -tocopherol binding protein (TAP). Its motifs suggest that
it is a member of the hydrophobic ligand-binding protein family
(CRAL-TRIO). TAP may also be involved in the regulation of cellular
-tocopherol concentration and -tocopherol–mediated
signaling.
KEY WORDS: • tocotrienols • tocopherols • cell signaling • -tocopherol binding protein
|
INTRODUCTION |
|---|
|
TOPABSTRACTINTRODUCTIONInhibition of PKC and...Transcriptional regulation of...{alpha}-Tocopherol-associated...REFERENCES |
|---|
. Later, in the 1960s,
it was associated with antioxidant function (2)
;
nonoxidant properties were discovered 25 y after that
(3
,4)
. -Tocopherol is the member of the vitamin E group
(-, ß-, 
- and 
-tocopherols and tocotrienols) with the most
biologically significant properties (5
6
7
8
9)
. Unlike others
in the vitamin E group, -tocopherol is found predominantly in
mammalian tissue, rather than in plants (10
11
12
13)
.
When -tocopherol is attacked by fatty acid peroxy radicals, it
becomes, via one-electron oxidation, the -tocopheryl radical; as
a consequence of two-electron oxidation, it becomes
-tocopherylquinone. Under physiologic conditions, the reducing
agents, ascorbic acid and lypoic acid, continuously repair oxidized
-tocopherol, thus preventing a loss of -tocopherol–dependent
cell-signaling events. If the rate of oxidation is greater than the
rate of repair, -tocopherol concentrations in the body will
decrease.
Low levels of -tocopherol have been associated with increased
incidence of coronary artery disease. Conversely, increased intake of
-tocopherol has been shown to have protective effects against heart
disease. Advances have been made in understanding the molecular basis
of atherogenesis, elucidating functions of -tocopherol beyond that
of preventing LDL oxidation. We are on the verge of understanding the
regulatory, nonoxidative response to -tocopherol by crucial cells.
Such responses include inhibition of smooth muscle cell proliferation,
preservation of endothelial function, inhibition of
monocyte-endothelial adhesion, inhibition of monocyte reactive
oxygen species and cytokine release, and inhibition of platelet
adhesion and aggregation.
These cellular responses to -tocopherol are associated with
transcriptional and post-transcriptional events. Activation of
diacylglycerol kinase and protein phosphatase 2A
(PP2A),4
and the inhibition of protein kinase C (PKC), cyclooxygenase,
lipoxygenase and cytokine release by -tocopherol are all examples of
post-transcriptional regulation. -Tocopherol also modulates the
transcriptional regulation of a number of genes, including the liver
collagen I gene, the -tocopherol transfer protein gene, the
-tropomyosin gene and the collagenase (metallo-proteinase 1) gene.
In recent years, several reviews have reported on the action of
-tocopherol at the cellular level (14
15
16
17
18
19
20)
. This brief
report will emphasize the nonantioxidant role of -tocopherol in
cellular modulation.
|
Inhibition of PKC and associated cellular functions |
|---|
|
TOPABSTRACTINTRODUCTIONInhibition of PKC and...Transcriptional regulation of...{alpha}-Tocopherol-associated...REFERENCES |
|---|
-tocopherol was discovered in
1991 to be the cause of the inhibition of vascular smooth muscle cell
proliferation by -tocopherol (3
,4
,21
22
23
24
25)
. Subsequent
reports have confirmed that the inhibition of PKC by -tocopherol
occurs in different cell types such as monocytes, macrophages,
neutrophils, fibroblasts and also mesangial cells
(14
,26
27
28
29
30
31
32
33
34
35
36
37
38)
. -Tocopherol was also found to inhibit
thrombin-induced PKC activation and endothelin secretion in
edothelial cells; ß-tocopherol did not have a similar ability
(39)
. -Tocopherol inhibits phorbol ester–induced shape
changes in erythroleukemia cells (40)
, and also inhibits
PKC-mediated neutrophil-superoxide generation (31)
. In
animal models of atherosclerosis, PKC inhibition by -tocopherol has
also been demonstrated (41
,42)
. -Tocopherol inhibits
PKC activity in a specific manner because ß-tocopherol or Trolox
(43)
does not exert such an effect. -Tocopherol also
produces a significant decrease in monocyte superoxide anion release,
lipid oxidation, and interleukin-1 (IL-1 ß) release and adhesion to
the endothelium. A similar antioxidant, ß-tocopherol, had no effect
on IL-1 ß release (44)
. -Tocopherol inhibits
production of chemokines and inflammatory cytokines in addition to
inhibition of adhesion of monocytes to human aortic endothelial cells
by reducing the expression of adhesion molecules when cells are
activated by inflammatory cytokines (45)
.
The proliferation and inhibition of PKC by a physiologic concentration
of -tocopherol are parallel events in vascular smooth muscle cells
(46
47
48)
. ß-Tocopherol is ineffective in either process
and prevents the inhibitory effect of -tocopherol. Because
-tocopherol and ß-tocopherol have very similar
radical-scavenging abilities, it is clear that the mechanism by
which -tocopherol acts on PKC is not related to these scavenging
properties (49)
. Inhibition by -tocopherol may be seen
only at the cellular level and is not evident with recombinant PKC. The
inhibitory effect of -tocopherol on PKC can be correlated to a
dephosphorylation of PKC. PP2A can be
activated in vitro by treatment with -tocopherol
(50
,51)
. This event may be crucial to the
dephosphorylation of PKC and its subsequent decrease in activity.
-Tocopherol has a PKC-mediated protective effect on human
mesangial cells when exposed to high glucose concentrations
(37)
. Our group observed a similar protective effect
(50
, 51)
. In the studies of King’s group
(37)
, PKC ß-isoform expression was induced by high
glucose. Interestingly, high glucose is concurrently responsible for an
increase in diacylglycerol synthesis. It can be concluded that,
although the mechanism of PKC inhibition by -tocopherol has been
interpreted differently in different laboratories and cellular systems,
considerable agreement exists concerning the inhibition of PKC by
-tocopherol.
|
Transcriptional regulation of cellular reactions |
|---|
|
TOPABSTRACTINTRODUCTIONInhibition of PKC and...Transcriptional regulation of...{alpha}-Tocopherol-associated...REFERENCES |
|---|
-Tocopherol concentration in organisms is dependent upon its
uptake and destruction in radical reactions. Because of this,
modulation of gene expression takes place as -tocopherol
concentrations increase or decrease (52)
. -Tropomyosin
expression is upregulated by -tocopherol, but not by ß-tocopherol,
in rat vascular smooth muscle cells (53)
in a reaction not
mediated by PKC. Age-dependent increase of collagenase (MPP1)
expression can be reduced by -tocopherol (54)
in human
skin fibroblasts.
The liver -tocopherol transfer protein and its mRNA are modulated by
dietary vitamin E deficiencies in rats (55)
, and - and
ß-tocopherol induce expression of hepatic -tocopherol transfer
protein mRNA (56
,57)
. Scavenger receptors are also under
-tocopherol control. -Tocopherol downregulates the activity of
class A scavenger receptors in macrophages (58)
. Another
scavenger receptor gene, CD36, is downregulated at the transcriptional
level by -tocopherol in macrophages and smooth muscles cells.
ß-Tocopherol, however, does not have this regulating ability
(59)
. In conclusion, it appears that -tocopherol is
able to regulate the expression of a number of genes that are
correlated with -tocopherol–associated pathologies. To what extent
these regulatory events are the direct consequence of the interaction
of -tocopherol with a receptor, a transcription factor or an element
of the signal transduction pathways (e.g., PKC or phosphatase) remains
a matter of
investigation.
|
-Tocopherol–associated protein (TAP)
|
|---|
|
TOPABSTRACTINTRODUCTIONInhibition of PKC and...Transcriptional regulation of...{alpha}-Tocopherol-associated...REFERENCES |
|---|
-tocopherol is involved in the regulation of
several genes offers a very challenging opportunity for future studies.
Here, only the existence of a common denominator (an -tocopherol
receptor protein, an -tocopherol sensitive promoter element or an
-tocopherol sensitive transcription factor) has been postulated.
Using molecular cloning into Escherichia coli and in vitro
expression, we recently identified a human (hTAP) and bovine TAP
(60)
. This protein appears to belong to a family of
hydrophobic ligand-binding proteins, which all have the CRAL
(cis-retinal binding motif) sequence in common. By using a
biotinylated -tocopherol derivative and the IASys resonant mirror
biosensor, the purified recombinant protein was shown to bind
tocopherol at a specific binding site with a
Kd of 4.6 x 10-7 mol/L. Northern
analysis shows that hTAP mRNA has a size of 
2.8k bp and is expressed
ubiquitously. The highest amounts of hTAP message are found in the
liver, brain and prostate. In conclusion, hTAP has significant sequence
homology with proteins containing the CRAL-TRIO structural motif
(RALBP, CRALBP, -TTP, SEC 14, PTN 9, RSEC 45). TAP binds
specifically to -tocopherol and biotinylated tocopherol, suggesting
the existence of a hydrophobic pocket possibly analogous to that of
SEC14. The newly discovered TAP is coded for in the human genome by three genes having slightly different 3'-sequences. The real function of these three genes products cannot be predicted precisely, but the very existence of three copies and their ubiquitous distribution point towards an important cellular role. Unbiased hypotheses may consider TAP a cellular binding or interorganelle transport protein, although the possibility of the identification of TAP with a cell receptor, a coreceptor or a transcription factor modulator cannot be underestimated. Coprecipitation experiments and two hybrid studies in progress in our laboratory may give indications, by nearest-neighbor protein interactions, concerning the function of these new cellular tocopherol binding proteins.
|
|
|
FOOTNOTES |
|---|
2 Supported by the Swiss National Science Foundation, by F. Hoffmann-La-Roche, AG and by the Stiftung für Ernährungsforschung in der Schweiz.
4 Abbreviations: IL, interleukin; PKC, protein kinase C; PP2A, protein phosphatase 2A; TAP, tocopherol-associated protein.
|
REFERENCES |
|---|
|
TOPABSTRACTINTRODUCTIONInhibition of PKC and...Transcriptional regulation of...{alpha}-Tocopherol-associated...REFERENCES |
|---|
1. Evans H. M., Bishop B.K.S. Fetal resorption. Science (Washington, DC) 1922;55:650
2. Epstein S. S., Forsyth J., Saporoschetz I. B., Mantel N. An exploratory investigation on the inhibition of selected photosensitizers by agents of varying antioxidant activity. Radiat. Res. 1966;28:322-335[Medline]
3.
Boscoboinik D., Szewczyk A., Azzi A. -Tocopherol (vitamin E) regulates vascular smooth muscle cell proliferation and protein kinase C activity. Arch. Biochem. Biophys. 1991;286:264-269[Medline]
4.
Boscoboinik D., Szewczyk A., Hensey C., Azzi A. Inhibition of cell proliferation by -tocopherol. Role of protein kinase C. J. Biol. Chem. 1991;266:6188-6194
5.
Ingold K. U., Burton G. W., Foster D. O., Hughes L., Lindsay D. A., Webb A. Biokinetics of and discrimination between dietary RRR- and SRR--tocopherols in the male rat. Lipids 1987;22:163-172[Medline]
6.
Kiyose C., Muramatsu R., Kameyama Y., Ueda T., Igarashi O. Biodiscrimination of -tocopherol stereoisomers in humans after oral administration [see comments]. Am. J. Clin. Nutr. 1997;65:785-789
7.
Weiser H., Vecchi M. Stereoisomers of -tocopheryl acetate—characterization of the samples by physico-chemical methods and determination of biological activities in the rat resorption-gestation test. Int. J. Vitam. Nutr. Res. 1981;51:100-113[Medline]
8.
Weiser H., Vecchi M., Schlachter M. Stereoisomers of -tocopheryl acetate. IV. USP units and -tocopherol equivalents of all-rac-, 2-ambo- and RRR--tocopherol evaluated by simultaneous determination of resorption-gestation, myopathy and liver storage capacity in rats. Int. J. Vitam. Nutr. Res. 1986;56:45-56[Medline]
9. Weber P., Bendich A., Machlin L. J. Vitamin E and human health: rationale for determining recommended intake levels. Nutrition 1997;13:450-460[Medline]
10. Netscher T. Stereoisomers of tocopherols—synthesis and analytics. Chimia 1996;50:563-567
11. Bauernfeind J. C. The tocopherol content of food and influencing factors. CRC Crit. Rev. Food Sci. Nutr. 1977;8:337-382[Medline]
12. Threlfall D. R. The biosynthesis of vitamins E and K and related compounds. Vitam. Horm. 1971;29:153-200[Medline]
13. Bauernfeind J. B. Vitamin E: A Comprehensive Treatise 1980:99-167 Marcel Dekker, Inc New York, NY.
14.
Devaraj S., Jialal I. The effects of -tocopherol on critical cells in atherogenesis. Curr. Opin. Lipidol. 1998;9:11-15[Medline]
15. Gokce N., Frei B. Basic research in antioxidant inhibition of steps in atherogenesis. J. Cardiovasc. Risk 1996;3:352-357[Medline]
16.
Frei B. On the role of vitamin C and other antioxidants in atherogenesis and vascular dysfunction. Proc. Soc. Exp. Biol. Med. 1999;222:196-204
17. Steiner M. Vitamin E: more than an antioxidant. Clin. Cardiol. 1993;16:I16-I118[Medline]
18. Wu H. P., Tai T. Y., Chuang L. M., Lin B. J., Wang J. D., Teng C. M. Effect of tocopherol on platelet aggregation in non-insulin-dependent diabetes mellitus: ex vivo and in vitro studies. J. Formos. Med. Assoc. 1992;91:270-275[Medline]
19. Steiner M. Influence of vitamin E on platelet function in humans. J. Am. Coll. Nutr. 1991;10:466-473[Abstract]
20.
Traber M., Packer L. Vitamin E: beyond antioxidant function. Am. J. Clin. Nutr. 1995;62:1501S-1509S
21. Azzi A., Boscoboinik D., Hensey C. The protein kinase C family. Eur. J. Biochem. 1992;208:547-557[Medline]
22.
Azzi A., Boscoboinik D., Chatelain E., Özer N. K., Stäuble B. d--Tocopherol control of cell proliferation. Mol. Asp. Med. 1993;14:265-271
23. Chatelain E., Boscoboinik D. O., Bartoli G. M., Kagan V. E., Gey F. K., Packer L., Azzi A. Inhibition of smooth muscle cell proliferation and protein kinase C activity by tocopherols and tocotrienols. Biochim. Biophys. Acta 1993;1176:83-89[Medline]
24. Boscoboinik D., Chatelain E., Bartoli G. M., Azzi A. Emerit I. Chance B. eds. Free Radicals and Aging 1992:164-177 Birkhäuser, Verlag, Basel Switzerland
25.
Tasinato A., Boscoboinik D., Bartoli G. M., Maroni P., Azzi A. d--Tocopherol inhibition of vascular smooth muscle cell proliferation occurs at physiological concentrations, correlates with protein kinase C inhibition, and is independent of its antioxidant properties. Proc. Natl. Acad. Sci. U.S.A. 1995;92:12190-12194
26. Devaraj S., Li D., Jialal I. The effects of alpha tocopherol supplementation on monocyte function. Decreased lipid oxidation, interleukin 1 beta secretion, and monocyte adhesion to endothelium. J. Clin. Investig. 1996;98:756-763[Medline]
27.
Devaraj S., Adams-Huet B., Fuller C. J., Jialal I. Dose-response comparison of RRR--tocopherol and all-racemic -tocopherol on LDL oxidation. Arterioscler. Thromb. Vasc. Biol. 1997;17:2273-2279
28.
Freedman J. E., Farhat J. H., Loscalzo J., Keaney J. F., Jr -Tocopherol inhibits aggregation of human platelets by a protein kinase C-dependent mechanism. Circulation 1996;94:2434-2440
29. Hehenberger K., Hansson A. High glucose-induced growth factor resistance in human fibroblasts can be reversed by antioxidants and protein kinase C-inhibitors. Cell Biochem. Funct. 1997;15:197-201[Medline]
30.
Kanno T., Utsumi T., Kobuchi H., Takehara Y., Akiyama J., Yoshioka T., Horton A. A., Utsumi K. Inhibition of stimulus-specific neutrophil superoxide generation by -tocopherol. Free Radic. Res. 1995;22:431-440[Medline]
31.
Kanno T., Utsumi T., Takehara Y., Ide A., Akiyama J., Yoshioka T., Horton A. A., Utsumi K. Inhibition of neutrophil-superoxide generation by -tocopherol and coenzyme Q. Free Radic. Res. 1996;24:281-289[Medline]
32. Okada S., Takehara Y., Yabuki M., Yoshioka T., Yasuda T., Inoue M., Utsumi K. Rapid reduction of nitric oxide by mitochondria, and reversible inhibition of mitochondrial respiration by nitric oxide. Biochem. J. 1996;315:295-299
33.
Koya D., Lee I. K., Ishii H., Kanoh H., King G. L. Prevention of glomerular dysfunction in diabetic rats by treatment with d--tocopherol. J. Am. Soc. Nephrol. 1997;8:426-435[Abstract]
34.
Rattan V., Sultana C., Shen Y. M., Kalra V. K. Oxidant stress-induced transendothelial migration of monocytes is linked to phosphorylation of PECAM-1. Am. J. Physiol. 1997;273:E453-E461
35. Skolnick A. A. Novel therapies to prevent diabetic retinopathy [news]. J. Am. Med. Assoc. 1997;278:1480-1481[Medline]
36. Studer R. K., Craven P. A., DeRubertis F. R. Antioxidant inhibition of protein kinase C-signaled increases in transforming growth factor-ß in mesangial cells. Metabolism 1997;46:918-925[Medline]
37.
Tada H., Ishii H., Isogai S. Protective effect of d--tocopherol on the function of human mesangial cells exposed to high glucose concentrations. Metabolism 1997;46:779-784[Medline]
38. Takehara Y., Kanno T., Yoshioka T., Inoue M., Utsumi K. Oxygen-dependent regulation of mitochondrial energy metabolism by nitric oxide. Arch. Biochem. Biophys. 1995;323:27-32[Medline]
39.
Martin-Nizard F., Boullier A., Fruchart J. C., Duriez P. -Tocopherol but not ß-tocopherol inhibits thrombin-induced PKC activation and endothelin secretion in endothelial cells. J. Cardiovasc. Risk 1998;5:339-345[Medline]
40.
Steiner M., Li W., Ciaramella J. M., Anagnostou A., Sigounas G. dl--Tocopherol, a potent inhibitor of phorbol ester induced shape change of erythro- and megakaryoblastic leukemia cells. J. Cell. Physiol. 1997;172:351-360[Medline]
41. Özer N. K., Sirikci Ö, Taha S., San T., Moser U., Azzi A. Effect of vitamin E and probucol on dietary cholesterol-induced atherosclerosis in rabbits. Free Radic. Biol. Med. 1998;24:226-233[Medline]
42. Sirikci Ö, Özer N. K., Azzi A. Dietary cholesterol-induced changes of protein kinase C and the effect of vitamin E in rabbit aortic smooth muscle cells. Atherosclerosis 1996;126:253-263[Medline]
43.
Cachia O., El Benna J., Pedruzzi E., Descomps B., Gougerot-Pocidalo M. A., Leger C. L. -Tocopherol inhibits the respiratory burst in human monocytes—attenuation of p47phox membrane translocation and phosphorylation. J. Biol. Chem. 1998;273:32801-32805
44.
Devaraj S., Jialal I. -Tocopherol decreases interleukin-1ß release from activated human monocytes by inhibition of 5-lipoxygenase. Arterioscler. Thromb. Vasc. Biol. 1999;19:1125-1133
45. Wu D., Koga T., Martin K. R., Meydani M. Effect of vitamin E on human aortic endothelial cell production of chemokines and adhesion to monocytes. Atherosclerosis 1999;147:297-307[Medline]
46. Gey K. F. The antioxidant hypothesis of cardiovascular disease: epidemiology and mechanisms. Biochem. Soc. Trans. 1990;18:1041-1045[Medline]
47.
Schultz M., Leist M., Petrzika M., Gassmann B., Brigelius-Flohé R. Novel urinary metabolite of -tocopherol, 2,5,7,8-tetramethyl- 2(2'-carboxyethyl)-6-hydroxychroman, as an indicator of an adequate vitamin E supply. Am. J. Clin. Nutr. 1995;62(suppl.):1527S-1534S
48.
Traber M. G., Ramakrishnan R., Kayden H. J. Human plasma vitamin E kinetics demonstrate rapid recycling of plasma RRR--tocopherol. Proc. Natl. Acad. Sci. U.S.A. 1994;91:10005-10008
49. Pryor A. W., Cornicelli J. A., Devall L. J., Tait B., Trivedi B. K., Witiak D. T., Wu M. A rapid screening test to determine the antioxidant potencies of natural and synthetic antioxidants. J. Org. Chem. 1993;58:3521-3532
50.
Ricciarelli R., Tasinato A., Clément S., Özer N. K., Boscoboinik D., Azzi A. -Tocopherol specifically inactivates cellular protein kinase C alpha by changing its phosphorylation state. Biochem. J. 1998;334:243-249
51.
Clement S., Tasinato A., Boscoboinik D., Azzi A. The effect of -tocopherol on the synthesis, phosphorylation and activity of protein kinase C in smooth muscle cells after phorbol 12-myristate 13-acetate down-regulation. Eur. J. Biochem. 1997;246:745-749[Medline]
52.
Azzi A., Boscoboinik D., Fazzio A., Marilley D., Maroni P., Ozer N. K., Spycher S., Tasinato A. RRR--Tocopherol regulation of gene transcription in response to the cell oxidant status. Z. Ernaehrwiss. 1998;37:21-28
53.
Aratri E., Spycher S. E., Breyer I., Azzi A. Modulation of -tropomyosin expression by -tocopherol in rat vascular smooth muscle cells. FEBS Lett 1999;447:91-94[Medline]
54.
Ricciarelli R., Maroni P., Ozer N., Zingg J., Azzi A. Age-dependent increase of collagenase expression can be reduced by -tocopherol via protein kinase C inhibition. Free Radic. Biol. Med. 1999;27:729-737[Medline]
55.
Shaw H. M., Huang C. Liver -tocopherol transfer protein and its mRNA are differentially altered by dietary vitamin E deficiency and protein insufficiency in rats. J. Nutr. 1998;128:2348-2354
56.
Fechner H., Schlame M., Guthmann F., Stevens P. A., Rustow B. - and -Tocopherol induce expression of hepatic - tocopherol-transfer-protein mRNA. Biochem. J. 1998;331:577-581
57.
Kim H. S., Arai H., Arita M., Sato Y., Ogihara T., Inoue K., Mino M., Tamai H. Effect of -tocopherol status on -tocopherol transfer protein expression and its messenger RNA level in rat liver. Free Radic. Res. 1998;28:87-92[Medline]
58.
Teupser D., Thiery J., Seidel D. -Tocopherol down-regulates scavenger receptor activity in macrophages. Atherosclerosis 1999;144:109-115[Medline]
59.
Ricciarelli R., Zingg J.-M., Azzi A. Downregulation of the CD36 scavenger receptor by -tocopherol. Circulation 2000;102:82-87
60. Stocker A., Zimmer S., Spycher S. E., Azzi A. Identification of a novel cytosolic tocopherol-binding protein: structure, specificity, and tissue distribution. JUBMB 1999;48:49-55
This article has been cited by other articles:
|
|
 |
|
  R. Siekmeier, C. Steffen, and W. Marz Role of Oxidants and Antioxidants in Atherosclerosis: Results of In Vitro and In Vivo Investigations Journal of Cardiovascular Pharmacology and Therapeutics, December 1, 2007; 12(4): 265 - 282. [Abstract] [PDF]
|
|
|
|
 |
|
 I. Kolleck, P. Sinha, and B. Rustow Vitamin E as an Antioxidant of the Lung: Mechanisms of Vitamin E Delivery to Alveolar Type II Cells Am. J. Respir. Crit. Care Med., December 15, 2002; 166(12): S62 - 66. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Gopalakrishna and U. Gundimeda Antioxidant Regulation of Protein Kinase C in Cancer Prevention J. Nutr., December 1, 2002; 132(12): 3819S - 3823. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. N. Hodis, W. J. Mack, L. LaBree, P. R. Mahrer, A. Sevanian, C.-r. Liu, C.-h. Liu, J. Hwang, R. H. Selzer, S. P. Azen, et al. Alpha-Tocopherol Supplementation in Healthy Individuals Reduces Low-Density Lipoprotein Oxidation but Not Atherosclerosis: The Vitamin E Atherosclerosis Prevention Study (VEAPS) Circulation, September 17, 2002; 106(12): 1453 - 1459. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. Qureshi, W. A. Salser, R. Parmar, and E. E. Emeson Novel Tocotrienols of Rice Bran Inhibit Atherosclerotic Lesions in C57BL/6 ApoE-Deficient Mice J. Nutr., October 1, 2001; 131(10): 2606 - 2618. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
